272
Views
1
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Microencapsulated krill and tuna oil blend raises plasma long-chain n-3 polyunsaturated fatty acid levels compared to tuna oil with similar increases in ileal contractility in rats

, , , , , & show all
Pages 201-209 | Received 10 May 2016, Accepted 10 Aug 2016, Published online: 18 Sep 2016

References

  • Abeywardena MY, Belobrajdic DP. 2016. Long-chain omega-3 polyunsaturated fatty acids and obesity. In: Obesity: a practical guide. Cham: Springer International Publishing. p. 29–44.
  • Albert BB, Derraik JG, Cameron-Smith D, Hofman PL, Tumanov S, Villas-Boas SG, Garg ML, Cutfield WS. 2015. Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci Rep. 5:7928.
  • Arterburn LM, Boswell KD, Henwood SM, Kyle DJ. 2000. A developmental safety study in rats using DHA- and ARA-rich single cell oils. Food Chem Toxicol. 38:763–771.
  • Atkinson TG, Barker HJ, Meckling-Gill KA. 1997. Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats. Lipids. 32:293–302.
  • Augustin MA, Patten G, De Luca A, Abeywardena M, Lockett T, Head R, Sanguansri L. 2011. Intestinal passage of microencapsulated fish oil in rats following oral administration. Food Funct. 2:684–696.
  • Bougnoux P, Hajjaji N, Maheo K, Couet C, Chevalier S. 2010. Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res. 49:76–86.
  • Calder PC. 2015. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta. 1851:469–484.
  • Calviello G, Serini S, Piccioni E. 2007. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr Med Chem. 14:3059–3069.
  • Calviello G, Serini S, Piccioni E. 2008. Alzheimer's disease and n-3 polyunsaturated fatty acids: beneficial effects and possible molecular pathways involved. Curr Signal Trans Ther. 3:152–157.
  • Del Gobbo LC, Imamura F, Aslibekyan S, Markland M, Virtanen JK, Wennberg M, Yakoob MY, Chiuve SE, Dela Cruz L, Frazier-Wood AC, et al. 2016. ω-3 polyunsaturated fatty acid biomarkers and coronary heart disease: Pooling project of 19 cohort studies. JAMA Intern Med. 176:1155–1166.
  • Fetterman JW Jr., Zdanowicz MM. 2009. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm. 66:1169–1179.
  • Flock MR, Harris WS, Kris-Etherton PM. 2013a. Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Nutr Rev. 71:692–707.
  • Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, Kris-Etherton PM. 2013b. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomised controlled trial. J Am Heart Assoc. 2:e000513.
  • Ghasemifard S, Turchini GM, Siclair AJ. 2014. Omega-3 long chain fatty acid “evidence and methodological considerations”: a review of evidence and methodological. Prog Lipid Res. 56:92–108.
  • Ghasemifard S, Hermon K, Turchini GM, Sinclair AJ. 2015. Metabolic fate (absorption, β-oxidation and deposition) of long-chain n-3 fatty acids is affected by sex and by the oil source (krill oil or fish oil) in the rat. Br J Nutr. 114:684–692.
  • Grieger JA, Miller M, Cobiac L. 2012. Knowledge and barriers relating to fish consumption in older Australians. Appetite. 59:456–463.
  • Gu Z, Suburu J, Chen H, Chen YQ. 2013. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. BioMed Res Int. 2013:824563. doi:http://dx.doi.org/10.1155/2013/824563.
  • Harris WS, Von Schacky C. 2004. The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med. 39:212–220.
  • Janssen CIF, Kiliaan AJ. 2014. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res. 53:1–17.
  • Kaur N, Chugh V, Gupta AK. 2014. Essential fatty acids as functional components of foods – a review. J Food Sci Technol. 51:2289–2303.
  • Kohler A, Sarkkinen E, Tapola N, Niskanen T, Bruheim I. 2015. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects-a randomized, single-dose, cross-over trial. Lipids Health Dis. 14:19.
  • Lockyer S, Rowland I, Spencer JPE, Yaqoob P, Stonehouse W. 2016. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randpmised controlled trial. Eur J Nutr. [Epub ahead of print]. doi:10.1007/s00394-016-1188-y
  • Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM. 2009. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res. 29:609–615.
  • Nestel P, Clifton P, Colquhoun D, Noakes M, Mori T, Sullivan D, Thomas B. 2015. Indications for omega-3 long chain polyunsaturated fatty acid in the prevention and treatment of cardiovascular disease. Heart Lung Circ. 24:769–779.
  • Nichols PD, McManus A, Krail K, Sinclair AJ, Miller M. 2014. Recent advances in omega-3: health benefits, sources, products and bioavailability. Nutrients. 6:3727–3733.
  • Opperman M, Benade S. 2013. Analysis of the omega-3 fatty acid content of South African fish oil supplements: a follow-up study. Cardiovasc J Afr. 24:297–302.
  • Ortega RM, Rodríguez-Rodríguez E, López-Sobaler AM. 2012. Effects of omega 3 fatty acids supplementation in behaviour and non-neurodegenerative neuropsychiatric disorders. Br J Nutr. 107:S261–S270.
  • Patten GS, Abeywardena MY, McMurchie EJ, Jahangiri A. 2002. Dietary fish oil increases acetylcholine- and eicosanoid-induced contractility of isolated rat ileum. J Nutr. 132:2506–2513.
  • Patten GS, Adams MJ, Dallimore JA, Abeywardena MY. 2005a. Dietary fish oil dose-response effects on ileal phospholipid fatty acids and contractility. Lipids. 40:925–929.
  • Patten GS, Adams MJ, Dallimore JA, Rogers PF, Topping DL, Abeywardena MY. 2005b. Restoration of depressed prostanoid-induced ileal contraction in spontaneously hypertensive rats by dietary fish oil. Lipids. 40:69–79.
  • Patten GS, Augustin MA, Sanguansri L, Head RJ, Abeywardena MY. 2009. Site specific delivery of microencapsulated fish oil to the gastrointestinal tract of the rat. Dig Dis Sci. 54:511–521.
  • Ramprasath VR, Eyal I, Zchut S, Jones PJ. 2013. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids Health Dis. 12:178. Available from: http://www.lipidworld.com/content/12/1/178.
  • Ramsvik MS, Bjorndal B, Bruheim I, Bohov P, Berge RK. 2015. A phospholipid-protein complex from krill with antioxidative and immunomodulating properties reduced plasma triacylglycerol and hepatic lipogenesis in rats. Mar Drugs. 13:4375–4397.
  • Reeves PG, Nielsen FH, Fahey GC. Jr. 1993. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr. 123:1939–1951.
  • Rosenquist A, Holmer G. 1996. Nutritional value of micro-encapsulated fish oils in rats. Z Ernahrungswiss. 35:178–184.
  • Sanguansri L, Day L, Shen Z, Fagan P, Weerakkody R, Cheng LJ, Rusli J, Augustin MA. 2013. Encapsulation of mixtures of tuna oil, tributyrin and resveratrol in a spray dried powder formulation. Food Funct. 4:1794–1802.
  • Sanguansri L, Augustin MA, Lockett TJ, Abeywardena MY, Royle PJ, Mano MT, Patten GS. 2015. Bioequivalence of n-3 fatty acids from microencapsulated fish oil formulations in human subjects. Br J Nutr. 113:822–831.
  • Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A. 2011. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis. 10:145. Available from: http://www.lipdworld.com/content/10/1/145.
  • Suarez A, del Carmen Ramirez M, Faus MJ, Gil A. 1996. Dietary long-chain polyunsaturated fatty acids influence tissue fatty acid composition in rats at weaning. J Nutr 126:887–897.
  • Tamjidi F, Nasirpour A, Shahedi M. 2012. Physicochemical and sensory properties of yogurt enriched with microencapsulated fish oil. Food Sci Technol Int. 18:381–390.
  • Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI. 2011. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 46:37–46.
  • Ulven SM, Holven KB. 2015. Comparison of bioavailability of krill oil versus fish oil and health effect. Vasc Health Risk Manag. 11:511–524.
  • van Schothorst EM, Flachs P, Franssen-van Hal NL, Kuda O, Bunschoten A, Molthoff J, Vink C, Hooiveld GJ, Kopecky J, Keijer J. 2009. Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. BMC Genomics. 10:110. Available from: http://biomedcentral.com/1471-2164/10/110.
  • Wallace JM, McCabe AJ, Robson PJ, Keogh MK, Murray CA, Kelly PM, Marquez-Ruiz G, McGlynn H, Gilmore WS, Strain JJ. 2000. Bioavailability of n-3 polyunsaturated fatty acids (PUFA) in foods enriched with microencapsulated fish oil. Ann Nutr Metab. 44:157–162.
  • Yep YL, Li D, Mann NJ, Bode O, Sinclair AJ. 2002. Bread enriched with microencapsulated tuna oil increases plasma docosahexaenoic acid and total omega-3 fatty acids in humans. Asia Pac J Clin Nutr. 11:285–291.
  • Young G, Conquer J. 2005. Omega-3 fatty acids and neuropsychiatric disorders. Repr Nutr Develop. 45:1–28.
  • Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N. Jr. 2015. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomised double-blind four-week bioavailability study. Lipids Health Dis. 14:99.
  • Zhu JJ, Shi JH, Qian WB, Cai ZZ, Li D. 2008. Effects of krill oil on serum lipids of hyperlipidemic rats and human SW480 cells. Lipids Health Dis. 7:30. doi: 10.1186/1476-511X7-30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.